Spaulding Clinical Research has created a clinical trial Center of Excellence. A full-service Phase I facility with top-of-the-line testing equipment and in-house measurement, analysis and reporting capabilities, we offer a seamless process that ensures quality control and eliminates the delay in data transfer that occurs at conventional testing facilities and ECG central labs.
In addition to being a comprehensive Phase I facility, Spaulding Clinical Research specializes in cardiac safety testing. In today's world, where rigorous scrutiny of cardiac safety data by the FDA is all but guaranteed, pharmaceutical companies require Phase I facilities to produce extremely high quality data that can pass this intensive review process, with no analysis or reporting delays. With the most advanced cardiac monitoring technology, in-house cardiac safety measurement, on-site ECG analysis automation, and more than 60 years of experience in cardiac care and safety, we provide the most accurate and timely assessments of cardiac risk in the early stages of new drug development.
At Spaulding Clinical Research, we also use an advanced quality management approach - allowing us to complete testing more quickly, reduce data acquisition time and eliminate variations in data measurement and analysis quality. No other Phase I facility offers this level of expertise or experience.